Literature DB >> 19082462

Mitochondrial ultrastructure-associated chemotherapy response in ovarian cancer.

Motoaki Saitou1, Seiji Isonishi, Tomomi Hamada, Takako Kiyokawa, Toshiaki Tachibana, Hiroshi Ishikawa, Makoto Yasuda.   

Abstract

We developed mitochondrial (MT) scoring system based on MT ultrastructural findings in association with response to chemotherapy in ovarian cancer (OC). Ultrathin sections of MT prepared from 28 OC patients before chemotherapy were examined by electron microscopy. Platinum-sensitive ovarian carcinoma cell line 2008 and its resistant variant C13 were used as control cells. Seven independent MT features including, diameter, pattern of cresta structure, electron density, distribution-density and -pattern, ratio of minimal/maximal diameter and MT architecture were examined and were assigned a score between 0 and 2. Twenty-eight cases were primary advanced OC, including 4 recurrent cases. Nine cases were chemosensitive while 19 were resistant. Univariate and multivariate analysis in each factor showed good correlation to chemosensitivity for 2 factors of electron density, distribution pattern. Total score of these 2 factors in 9 sensitive cells was 1.44+/-0.41 (M +/- SE) and was 3.58+/-0.18 in 19 resistant cells (P<0.001). Receptor operative characteristics (ROC) analysis revealed that total 'cut-off' score was 3 point (P<0.05; AUC=0.84). In conclusion, this MT scoring system was excellently correlated to response regardless of histopathologic findings and this strongly suggests that the system is deemed to be of great value as biomarker for the chemosensitivity in OC.

Entities:  

Mesh:

Year:  2009        PMID: 19082462

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  Prognostic significance of the mitochondrial scoring system in ovarian cancer.

Authors:  Ryuma Matsumoto; Seiji Isonishi; Kazuhiko Ochiai; Tomomi Hamada; Takako Kiyokawa; Toshiaki Tachibana; Hiroshi Ishikawa
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

2.  Down-regulation of Ras-related protein Rab 5C-dependent endocytosis and glycolysis in cisplatin-resistant ovarian cancer cell lines.

Authors:  Lixu Jin; Yi Huo; Zhiguo Zheng; Xiaoyong Jiang; Haiyun Deng; Yuling Chen; Qingquan Lian; Renshan Ge; Haiteng Deng
Journal:  Mol Cell Proteomics       Date:  2014-08-05       Impact factor: 5.911

3.  Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublines.

Authors:  Ming Chen; Hong Huang; Haojie He; Wantao Ying; Xin Liu; Zhiqin Dai; Jie Yin; Ning Mao; Xiaohong Qian; Lingya Pan
Journal:  Cancer Sci       Date:  2015-07-24       Impact factor: 6.716

4.  Esophageal squamous cell carcinoma with low mitochondrial copy number has mesenchymal and stem-like characteristics, and contributes to poor prognosis.

Authors:  Yasunori Masuike; Koji Tanaka; Tomoki Makino; Makoto Yamasaki; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Kiyokazu Nakajima; Masaki Mori; Yuichiro Doki
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

5.  MnSOD Lysine 68 acetylation leads to cisplatin and doxorubicin resistance due to aberrant mitochondrial metabolism.

Authors:  Yucheng Gao; Yueming Zhu; Elizabeth L Tran; Valerie Tokars; Angela E Dean; Songhua Quan; David Gius
Journal:  Int J Biol Sci       Date:  2021-03-19       Impact factor: 6.580

6.  Comparative mitochondrial proteomics of Leishmania tropica clinical isolates resistant and sensitive to meglumine antimoniate.

Authors:  Minoo Tasbihi; Faezeh Shekari; Homa Hajjaran; Majid Khanmohammadi; Ramtin Hadighi
Journal:  Parasitol Res       Date:  2020-04-30       Impact factor: 2.289

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.